Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Equity Ratio (2018 - 2025)

Dna X (SONM) has disclosed Equity Ratio for 8 consecutive years, with 0.02 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio fell 105.58% year-over-year to 0.02, compared with a TTM value of 0.02 through Sep 2025, down 105.58%, and an annual FY2024 reading of 0.14, down 135.94% over the prior year.
  • Equity Ratio was 0.02 for Q3 2025 at Dna X, up from 0.04 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.48 in Q1 2021 and bottomed at 0.14 in Q4 2024.
  • Average Equity Ratio over 5 years is 0.28, with a median of 0.37 recorded in 2022.
  • The sharpest move saw Equity Ratio skyrocketed 114.24% in 2023, then crashed 135.94% in 2024.
  • Year by year, Equity Ratio stood at 0.45 in 2021, then decreased by 17.65% to 0.37 in 2022, then grew by 6.9% to 0.4 in 2023, then tumbled by 135.94% to 0.14 in 2024, then skyrocketed by 87.85% to 0.02 in 2025.
  • Business Quant data shows Equity Ratio for SONM at 0.02 in Q3 2025, 0.04 in Q2 2025, and 0.03 in Q1 2025.